کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2020023 | 1069087 | 2007 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells](/preview/png/2020023.png)
Phorbol-12-myristate-13-acetate (PMA) induces megakaryocytopoeisis in human erythroleukemia (HEL) cells which is characterized by the increase in cell size, increase in nuclear polyploidization and expression of megakaryocyte marker, CD41. However, upon treatment with 100 nM of selective prostacyclin (IP) agonist beraprost inhibits the induced differentiation. Moreover, selective non-prostanoid IP agonist, BMY 45778 prevents PMA induced megakaryocytopoeisis in HEL cells similarly, while prostaglandin E2 and specific EP3 agonist sulprostone have no effect. Thus, IP receptor is involved. Furthermore, adenylate cyclase activator forskolin and cAMP analog dibutyryl-cAMP also prevented PMA induced megakaryocytopoeisis in HEL cells. Thus, IP agonists inhibition of PMA induced megakaryocytopoeisis in HEL cells may involve a cAMP dependent pathway.
Journal: Prostaglandins & Other Lipid Mediators - Volume 83, Issue 3, May 2007, Pages 231–236